Literature DB >> 12527569

Initial evaluation of the patient with lung cancer: symptoms, signs, laboratory tests, and paraneoplastic syndromes.

Michael A Beckles1, Stephen G Spiro, Gene L Colice, Robin M Rudd.   

Abstract

This chapter describes the components of the initial evaluation for a patient either suspected or known to have lung cancer. The components of the initial evaluation are based on the recognized manifestations of localized lung cancer, ie, symptoms referable to the primary tumor, intrathoracic spread of lung cancer, and patterns of metastatic dissemination. Features of the history and physical signs may be useful indicators of the extent of disease. A standardized evaluation, relying on symptoms, signs, and routinely available laboratory tests, can serve as a useful screen for metastatic disease. Also described are the common features of the various paraneoplastic syndromes associated with lung cancer.

Entities:  

Mesh:

Year:  2003        PMID: 12527569     DOI: 10.1378/chest.123.1_suppl.97s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  49 in total

Review 1.  Lung carcinoma presenting as an obstructive jaundice: case series with literature review.

Authors:  Dhara Chaudhari; Atul Khanna; Puneet Goenka; Mark Young
Journal:  J Gastrointest Cancer       Date:  2014-12

2.  Estimating long-term effectiveness of lung cancer screening in the Mayo CT screening study.

Authors:  Pamela M McMahon; Chung Yin Kong; Bruce E Johnson; Milton C Weinstein; Jane C Weeks; Karen M Kuntz; Jo-Anne O Shepard; Stephen J Swensen; G Scott Gazelle
Journal:  Radiology       Date:  2008-05-05       Impact factor: 11.105

3.  Pain Quality by Location in Outpatients with Cancer.

Authors:  Judith M Schlaeger; Li-Chueh Weng; Hsiu-Li Huang; Hsiu-Hsin Tsai; Miho Takayama; Srisuda Ngamkham; Yingwei Yao; Diana J Wilkie
Journal:  Pain Manag Nurs       Date:  2019-05-31       Impact factor: 1.929

4.  Peak oxygen consumption and long-term all-cause mortality in nonsmall cell lung cancer.

Authors:  Lee W Jones; Dorothy Watson; James E Herndon; Neil D Eves; Benjamin E Haithcock; Gregory Loewen; Leslie Kohman
Journal:  Cancer       Date:  2010-10-15       Impact factor: 6.860

5.  Isolated knee monoarthritis heralding resectable non-small-cell lung cancer. A paraneoplastic syndrome not previously described.

Authors:  Fabrizio Cantini; Laura Niccoli; Carlotta Nannini; Daniela Chindamo; Michele Bertoni; Emanuele Cassarà; Carlo Salvarani
Journal:  Ann Rheum Dis       Date:  2007-09-03       Impact factor: 19.103

6.  Determination of intra-axial brain tumors cellularity through the analysis of T2 Relaxation time of brain tumors before surgery using MATLAB software.

Authors:  Jamil Abdolmohammadi; Mohsen Shafiee; Fariborz Faeghi; Douman Arefan; Alireza Zali; Rouzbeh Motiei-Langroudi; Zahra Farshidfar; Ali Kiani Nazarlou; Ali Tavakkoli; Mohammad Yarham
Journal:  Electron Physician       Date:  2016-08-25

7.  Calibration of disease simulation model using an engineering approach.

Authors:  Chung Yin Kong; Pamela M McMahon; G Scott Gazelle
Journal:  Value Health       Date:  2009-01-12       Impact factor: 5.725

8.  Lung cancer at a University Hospital in Saudi Arabia: A four-year prospective study of clinical, pathological, radiological, bronchoscopic, and biochemical parameters.

Authors:  Omer S Alamoudi
Journal:  Ann Thorac Med       Date:  2010-01       Impact factor: 2.219

9.  The lung cancer exercise training study: a randomized trial of aerobic training, resistance training, or both in postsurgical lung cancer patients: rationale and design.

Authors:  Lee W Jones; Neil D Eves; William E Kraus; Anil Potti; Jeffrey Crawford; James A Blumenthal; Bercedis L Peterson; Pamela S Douglas
Journal:  BMC Cancer       Date:  2010-04-21       Impact factor: 4.430

10.  Identification of genes associated with multiple cancers via integrative analysis.

Authors:  Shuangge Ma; Jian Huang; Meena S Moran
Journal:  BMC Genomics       Date:  2009-11-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.